https://www.openbell.ai/ 2026-09-28T18:01:48.215Z hourly 1.0 https://www.openbell.ai/support 2026-09-28T18:01:48.215Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-28T18:01:48.215Z monthly 0.5 https://www.openbell.ai/terms 2026-09-28T18:01:48.215Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-28T18:01:48.215Z hourly 0.8 https://www.openbell.ai/news/VRTX:1790618449736 2026-09-28T18:00:49.736Z daily 0.9 https://cdn.brandfetch.io/VRTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $615 UBS analyst Michael Yee has reaffirmed a Buy rating on Vertex Pharmaceuticals (NASDAQ: VRTX) and increased the price target from $585 to $615. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/ETN:1790618405525 2026-09-28T18:00:05.525Z daily 0.9 https://cdn.brandfetch.io/ETN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of data center infrastructure-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://www.openbell.ai/news/USO:1790618202776 2026-09-28T17:56:42.776Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'White House weighs red-dyed diesel tax relief to lower fuel prices' - Reuters The White House is considering tax relief on red-dyed diesel fuel as a measure to reduce fuel prices. This potential policy change aims to alleviate the financial burden on consumers and businesses facing rising fuel costs. The move could have significant implications for the market, particularly affecting companies reliant on diesel fuel. https://www.openbell.ai/news/CRON:1790618152812 2026-09-28T17:55:52.812Z daily 0.9 https://cdn.brandfetch.io/CRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Securities Maintains Buy on Cronos Group, Raises Price Target to C$7 TD Securities analyst Derek Lessard has maintained a Buy rating on Cronos Group (TSX: CRON) and raised the price target from C$6 to C$7. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/MDB:1790618126144 2026-09-28T17:55:26.144Z daily 0.9 https://cdn.brandfetch.io/MDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud MongoDB shares are trading lower. The company announced its CEO Chirantan Desai has stepped down effective immediately to pursue a senior role at Meta Platforms. openbell Financial News https://www.openbell.ai/news/VRT:1790618094008 2026-09-28T17:54:54.008Z daily 0.9 https://cdn.brandfetch.io/VRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of data center infrastructure-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://www.openbell.ai/news/KNRX:1790617936775 2026-09-28T17:52:16.775Z daily 0.9 https://cdn.brandfetch.io/KNRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud KNOREX Pursues Strategic Carve-Out Of AscendX Media Technologies Subsidiary; AscendX Would Be Separated And Independently Capitalized With Investment From External Investors, And KNOREX Expects To Retain A Minority Equity Interest In AscendX KNOREX Ltd. is pursuing a strategic carve-out of its wholly owned subsidiary, AscendX Media Technologies, which focuses on publisher monetization. The proposed structure aims to separate AscendX and allow it to be independently capitalized through external investments, while KNOREX plans to retain a minority equity interest. This move is expected to relieve KNOREX from funding AscendX's future growth, enabling the company to focus on its KNOREX XPO™ platform and other strategic initiatives. https://www.openbell.ai/news/SMCI:1790617934603 2026-09-28T17:52:14.603Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Super-Micro-Computer--Inc.jpg?width=250&height=187 What's Going On With Super Micro Computer Stock Monday? Super Micro Computer, Inc. (NASDAQ: SMCI) saw its stock decline by nearly 3% on Monday, trading at $42.08, amid broader market pressures including a 0.87% drop in the Nasdaq and rising oil prices. The decline is attributed to a risk-off sentiment among investors, as the 10-year Treasury yield reached its highest level since 2007. Despite the drop, SMCI remains above its key moving averages and has a Hold consensus rating with an average price forecast of $39.50 from analysts. https://www.openbell.ai/news/MU:1790617858107 2026-09-28T17:50:58.107Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of memory and storage-related companies are trading lower. Elevated bond yields and Fed interest rate expectations are weighing on technology sectors that have exposure to AI buildout capex plans that may come under closer scrutiny from inflated borrowing costs. openbell Financial News https://www.openbell.ai/news/NTES:1790617779588 2026-09-28T17:49:39.588Z daily 0.9 https://cdn.brandfetch.io/NTES/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Reiterates Overweight on NetEase, Maintains $163 Price Target Morgan Stanley analyst Yang Liu has reiterated an Overweight rating on NetEase (NASDAQ: NTES) and maintained a price target of $163 for the stock. This endorsement suggests a positive outlook for NetEase in the market. https://www.openbell.ai/news/SPY:1790617678277 2026-09-28T17:47:58.277Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Wall-Street-And-New-Street--New-York--Us.jpg?width=250&height=187 $700 Billion S&P 500 Sell-Off Meets $100 Oil: Are Investors Rotating Into Value ETFs? On Monday, the S&P 500 experienced a significant sell-off, erasing nearly $700 billion in market capitalization as U.S. Treasury yields reached multi-year highs and oil prices approached $100 per barrel. The Nasdaq 100 fell 1.6%, while Brent crude rose 4% to $108.50, marking a 20% increase for September. The market is currently assessing whether this decline indicates a shift from growth-oriented investments to value-focused ETFs, particularly in sectors like energy and defensives, as the equal-weight S&P 500 also showed a 4% drop for the month. https://www.openbell.ai/news/MCD:1790617623886 2026-09-28T17:47:03.886Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Melius Research Maintains Sell on McDonald's, Lowers Price Target to $230 Melius Research analyst Jacob Aiken Phillips has maintained a 'Sell' rating on McDonald's (NYSE: MCD) and reduced the price target from $250 to $230. https://www.openbell.ai/news/PEP:1790617622643 2026-09-28T17:47:02.643Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Pepsi.jpg?width=250&height=187 This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ: PEP) from Buy to Hold and reduced the price target from $155 to $138, while PepsiCo's stock closed at $128.63 on Friday. This downgrade is part of a broader trend, as several companies, including RLJ Lodging Trust and Braskem SA, also experienced downgrades from various analysts. The changes reflect a cautious outlook on these stocks amid market conditions. https://www.openbell.ai/news/OKTA:1790617537192 2026-09-28T17:45:37.192Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Maintains Sector Outperform on Okta, Raises Price Target to $245 Scotiabank analyst Patrick Colville has reaffirmed a Sector Outperform rating for Okta (NASDAQ: OKTA) and increased the price target from $190 to $245. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/OKTA:1790617448590 2026-09-28T17:44:08.590Z daily 0.9 https://cdn.brandfetch.io/OKTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Okta shares are trading higher after Citizens maintained the stock with a Market Outperform rating and raised the price target from $180 to $225. openbell Financial News https://www.openbell.ai/news/BSX:1790617447572 2026-09-28T17:44:07.572Z daily 0.9 https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Flags Boston Scientific Catheter Recall Boston Scientific Corp (NYSE: BSX) is recalling all Imager II Angiographic Catheters due to a manufacturing defect that compromises patient safety, specifically a flaw in the catheter tip. The company has advised customers to immediately remove these products from inventory and is permanently discontinuing the product line. As of July 16, there have been two serious injuries linked to this issue, although no deaths have been reported. Following the announcement, Boston Scientific's shares fell 0.25% to $43.81, nearing its 52-week low of $42.20. https://www.openbell.ai/news/COIN:1790617439159 2026-09-28T17:43:59.159Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Keefe, Bruyette & Woods Reinstates Outperform on Coinbase Global, Announces $237 Price Target Keefe, Bruyette & Woods analyst Stephen Glagola has reinstated an 'Outperform' rating on Coinbase Global (NASDAQ: COIN) and set a price target of $237 for the stock. https://www.openbell.ai/news/BSX:1790617439023 2026-09-28T17:43:59.023Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Motala--Sweden--7-January-2023-Fda-Logo-.jpg?width=250&height=187 FDA Flags Boston Scientific Catheter Recall Boston Scientific Corp (NYSE: BSX) is recalling all Imager II Angiographic Catheters due to a manufacturing defect that compromises patient safety, specifically related to the catheter tip. The company has advised customers to immediately remove these products from inventory and has permanently discontinued the product line. As of July 16, there have been two serious injuries linked to this issue, although no deaths have been reported. Following the announcement, Boston Scientific shares fell 0.25% to $43.81, nearing its 52-week low of $42.20. https://www.openbell.ai/news/BSX:1790617376955 2026-09-28T17:42:56.955Z daily 0.9 https://cdn.brandfetch.io/BSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FDA Flags Boston Scientific Catheter Recall The FDA has announced a recall of all Imager II Angiographic Catheters from Boston Scientific Corp (NYSE: BSX) due to a manufacturing defect that compromises patient safety. The defect involves inadequate stabilizing agents in the catheter tip, which could lead to detachment during medical procedures, posing severe health risks. As of July 16, there have been two serious injuries reported linked to this issue, though no deaths. Following the recall announcement, Boston Scientific shares fell 0.25% to $43.81, nearing their 52-week low of $42.20. https://www.openbell.ai/news/ABBV:1790617114898 2026-09-28T17:38:34.898Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Dementia-In-Senior-People--Memory-Loss--.jpg?width=250&height=187 AbbVie’s New Parkinson’s Pill Could Become a Billion-Dollar Drug, Analyst Says AbbVie Inc. received FDA approval for its new Parkinson's medication, Juvmo (tavapadon), which is the first selective D1/D5 receptor agonist for adults with Parkinson's disease. The drug is expected to be available in the U.S. by October 2026, with an estimated list price of $4,900 for a 30-day supply. Analysts project Juvmo could generate $1.4 billion in sales by 2040, contributing to AbbVie's overall Parkinson's franchise, which is anticipated to reach at least $5 billion in peak sales. AbbVie shares rose 1.03% to $263.70, nearing a 52-week high. https://www.openbell.ai/news/LLY:1790617071522 2026-09-28T17:37:51.522Z daily 0.9 https://cdn.brandfetch.io/LLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud "Lilly CEO Eyes Bigger Deals in Hunt for Pharma’s ‘White Spaces’" - Bloomberg News Eli Lilly's CEO has expressed intentions to pursue larger acquisitions to explore untapped opportunities in the pharmaceutical sector, referred to as 'white spaces.' The company is focusing on expanding its portfolio through strategic deals to enhance growth. This approach aligns with Lilly's ongoing efforts to innovate and strengthen its market position. https://www.openbell.ai/news/META:1790616641556 2026-09-28T17:30:41.556Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Ljubljana--Slovenia---21-January-2023-Me.jpg?width=250&height=187 Meta Is Coming for Europe’s Bond Market: AI Debt Is Going Global Meta Platforms Inc (NASDAQ: META) is set to enter Europe's bond market for the first time this autumn as it seeks funding for its AI initiatives, marking a shift from U.S.-centric borrowing to a global approach. This move aligns with a trend among U.S. hyperscalers, who are increasingly tapping into euro-denominated debt, with such companies accounting for nearly 10% of new euro bond issuances. The European Central Bank estimates that hyperscalers may require over $1 trillion in capital expenditures by 2028, highlighting the growing need for diverse funding sources. https://www.openbell.ai/news/IONQ:1790616609592 2026-09-28T17:30:09.592Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Central-Processing-Unit-cpu-With-Circuit.jpg?width=250&height=187 IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch IonQ Inc. (NYSE: IONQ) received a Buy rating from BofA Securities, with a price target of $60, citing its semiconductor-based design as a pathway to scalable quantum computing. The company's stock has been volatile, currently trading at $47.15, approximately 44% below its 52-week high of $84.64. IonQ's Superion 256 system, set for customer deliveries in Q2 2027, is expected to feature 256 physical qubits and aims for over 80,000 logical qubits by 2030. BofA forecasts sales growth from $130 million in 2025 to $3.7 billion by 2030, reflecting a 69% compound annual growth rate from 2026 to 2030. https://www.openbell.ai/news/KOD:1790616500693 2026-09-28T17:28:20.693Z daily 0.9 https://cdn.brandfetch.io/KOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Kodiak Sciences, Raises Price Target to $120 UBS analyst Michael Yee has maintained a Buy rating on Kodiak Sciences (NASDAQ: KOD) and raised the price target from $80 to $120. This adjustment reflects positive sentiment regarding the company's performance and potential growth. https://www.openbell.ai/news/ROC:1790616480218 2026-09-28T17:28:00.218Z daily 0.9 https://cdn.brandfetch.io/ROC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Craig-Hallum Initiates Coverage On Rank One Computing with Buy Rating, Announces Price Target of $6.5 Craig-Hallum analyst Jeff Van Sinderen has initiated coverage on Rank One Computing (NASDAQ: ROC) with a Buy rating. The firm has set a price target of $6.50 for the stock. https://www.openbell.ai/news/MRVL:1790616300837 2026-09-28T17:25:00.837Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Marvell Technology; Hearing Zacks Tech Innovators Buys Stock openbell Financial News https://www.openbell.ai/news/PANW:1790616106845 2026-09-28T17:21:46.845Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Palo-Alto-Networks-Logo-And-Sign-At-Sili.jpg?width=250&height=187 Palo Alto’s AI Security Trio Could Fuel a Growth Surge, BTIG Says Palo Alto Networks Inc (NASDAQ: PANW) is expected to see significant revenue growth, with pro forma revenue projected to increase over 17% this year, surpassing the Street's expectation of 14.6%. Analyst Gray Powell raised the price target from $404 to $425, highlighting key products like Chronosphere, which has crossed $500 million in ARR and could exceed $800 million by FY27, and Prisma AIRS, expected to grow from $120 million to over $400 million in ARR by the end of FY27. Shares rose by 3.89% to $389.32 following the positive outlook. https://www.openbell.ai/news/BP:1790616015002 2026-09-28T17:20:15.002Z daily 0.9 https://cdn.brandfetch.io/BP/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'BP Is Said to Weigh Sale of Its Brazilian Biofuels Business' - Bloomberg News BP is reportedly considering the sale of its Brazilian biofuels business as part of a strategic review. This potential divestiture aligns with BP's broader efforts to streamline operations and focus on core areas. The decision comes amid ongoing shifts in the biofuels market and BP's commitment to transitioning towards renewable energy sources. https://www.openbell.ai/news/MU:1790615658934 2026-09-28T17:14:18.934Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Micron-Logo-Displayed-On-A-Smartphone-Sc.jpg?width=250&height=187 Micron Heads Into Earnings as JPMorgan Sees HBM Shortage Lasting Through 2028 JPMorgan analyst Harlan Sur anticipates that Micron Technology Inc. (NASDAQ: MU) will report strong memory pricing in its upcoming fourth-quarter earnings, with expectations for August-quarter revenue, gross margin, and EPS to exceed Wall Street estimates of $51.4 billion, 86.2%, and $31.73, respectively. Sur projects that DRAM and NAND prices will rise over 20% sequentially, and Micron's data-center business is expected to surpass a $100 billion annualized revenue run rate. Additionally, Sur forecasts that HBM shortages will persist through 2028, maintaining upward pressure on pricing, while Micron plans to return excess cash via share buybacks following its CHIPS Act deal anniversary. As of the report, Micron's stock was down 3.89% at $1040.18. https://www.openbell.ai/news/USO:1790615628198 2026-09-28T17:13:48.198Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading higher following reports suggesting President Trump rejected Iran's plan to reopen the Strait of Hormuz and that he may resume strikes on the country after the midterm election. Also, President Trump is weighing a diesel export ban, which would contribute to ongoing global supply constraints. openbell Financial News https://www.openbell.ai/news/MBD:1790615501114 2026-09-28T17:11:41.114Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: MongoDB Stock Craters 18% after CEO Departure to Meta MongoDB Inc. (NASDAQ: MBD) shares fell by 18.5% following the unexpected resignation of CEO Chirantan Desai, who is joining Meta Platforms. Dev Ittycheria, the former CEO, has returned as interim president and CEO. Despite this leadership change, MongoDB maintained its guidance for the third quarter with adjusted EPS projected at $1.57-$1.61, exceeding the $1.54 consensus, and fiscal 2027 EPS expected at $6.39-$6.58, above the $6.13 estimate. https://www.openbell.ai/news/KNRX:1790615164291 2026-09-28T17:06:04.291Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Communication Services Stocks Moving In Monday's Intraday Session On Monday, Knorex (AMEX: KNRX) saw a significant increase of 301.3%, reaching $1.22, with a market value of $9.2 million. Other notable gainers included Intelligent Group (NASDAQ: INTJ) which rose 21.48% to $3.28, and Able View Global (NASDAQ: ABLV) which increased by 19.23% to $1.55. Conversely, TEN Hldgs (NASDAQ: XHLD) experienced a sharp decline of 92.7%, falling to $0.94, while Treasure Global (NASDAQ: TGL) dropped 30.52% to $1.48. https://www.openbell.ai/news/KOD:1790615164094 2026-09-28T17:06:04.094Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Health Care Stocks Moving In Monday's Intraday Session On Monday, Kodiak Sciences (NASDAQ: KOD) saw its shares surge by 172.3% to $88.08, bringing its market value to $2.0 billion. Other notable gainers included Accuray (NASDAQ: ARAY) with a 58.27% increase to $0.34 and Lifecore Biomedical (NASDAQ: LFCR) which rose by 55.98% to $6.55. Conversely, MediciNova (NASDAQ: MNOV) experienced a significant decline of 32.0%, dropping to $1.75, while NewGenIvf Group (NASDAQ: NIVF) fell by 30.43% to $0.39. https://www.openbell.ai/news/SOAR:1790615163833 2026-09-28T17:06:03.833Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Industrials Stocks Moving In Monday's Intraday Session On Monday, Volato Group (AMEX: SOAR) shares surged by 133.1% to $0.42, with a market cap of $9.6 million. Other notable gainers included Enigmatig (AMEX: EGG), which rose 44.64% to $4.05, and Mint (NASDAQ: MIMI), increasing by 22.17% to $0.94. Conversely, Masonglory (NASDAQ: MSGY) experienced the largest decline, dropping 57.9% to $3.4, while Green Circle Decarbonize (AMEX: GCDT) fell 21.54% to $0.53. https://www.openbell.ai/news/CLRO:1790615163632 2026-09-28T17:06:03.632Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Monday's Intraday Session On Monday, ClearOne (NASDAQ: CLRO) saw its stock price surge by 44.5% to $4.98, with a market capitalization of $9.2 million. Other notable gainers included MagnaChip Semiconductor (NYSE: MX), which rose 19.39% to $3.94, and Cango (NYSE: CANG), up 17.27% to $2.24. Conversely, Gen Digital Inc. (NASDAQ: GENVR) experienced a significant decline, with its stock falling 20.9% to $0.87, while MongoDB (NASDAQ: MDB) dropped 17.63% to $338.09, maintaining a market value of $33.0 billion. https://www.openbell.ai/news/ZYME:1790615155146 2026-09-28T17:05:55.146Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Merger-And-Acquisition-Business-Corporat.jpg?width=250&height=187 Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal Zymeworks Inc. has finalized its acquisition of Theravance Biopharma and updated its financial guidance for fiscal year 2026, projecting revenue between $278 million and $292 million and adjusted EBITDA of $114 million to $128 million. The acquisition adds YUPELRI to Zymeworks' portfolio, which generated $133.1 million in sales in the first half of 2026, and the company expects a mid-teens internal rate of return from this deal. Zymeworks shares rose 2.34% to $27.14 following the announcement. https://www.openbell.ai/news/MDB:1790615013053 2026-09-28T17:03:33.053Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/President-Trump-Auto-Tariffs-Announcemen.jpg?width=250&height=187 Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today U.S. stocks declined on Monday, with the Nasdaq 100 falling 1.3% to 30,223, as oil prices surged following President Trump's rejection of Iran's Hormuz proposal. West Texas Intermediate crude oil futures rose 4.2% to $96.31 a barrel, while the 10-year Treasury yield reached 5.27%, its highest since 2007. Notably, MongoDB, Inc. saw a significant drop of 18.5% after its CEO stepped down unexpectedly, despite the company reaffirming its third-quarter and fiscal 2027 guidance above estimates. https://www.openbell.ai/news/GETY:1790614730245 2026-09-28T16:58:50.245Z daily 0.9 https://cdn.brandfetch.io/GETY/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Getty Images in Talks With Lenders for Potential Bankruptcy Loan' - Bloomberg Getty Images is currently in discussions with lenders to secure a potential bankruptcy loan as it faces financial challenges. The company is exploring options to stabilize its operations amid these difficulties. The stock ticker for Getty Images is GETY. https://www.openbell.ai/news/HUBS:1790614664704 2026-09-28T16:57:44.704Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/HubSpot.jpg?width=250&height=187 What's Going On With HubSpot Stock Monday? HubSpot Inc. (NYSE: HUBS) stock dropped 5.46% to $202.07 on Monday, influenced by rising oil prices and Treasury yields that negatively impacted software stocks. The stock is currently trading 19.4% below its 200-day moving average, indicating a bearish trend. Analysts maintain a Buy consensus rating with price forecasts ranging from $250 to $275, while the stock has a price-to-earnings ratio of approximately 76.1. https://www.openbell.ai/news/FTAI:1790614610052 2026-09-28T16:56:50.052Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Logo-For-FTAI-Aviation-Ltd.jpg?width=250&height=187 FTAI Acquires 27 Boeing 737-700s to Expand Aviation Businesses FTAI Aviation Ltd. has acquired 27 Boeing 737-700 aircraft from WestJet, which includes 17 leased through a sale-leaseback arrangement and 10 off-lease aircraft for its Aerospace Products business. Following this acquisition, FTAI's stock fell by over 3%, trading at $169.55. The company has also secured a five-year maintenance capacity agreement with PT Garuda Maintenance Facility Aero Asia, enhancing its engine maintenance capabilities. FTAI is expected to report earnings on October 26, with estimates of $1.01 billion in revenue and an EPS of $1.35. https://www.openbell.ai/news/BUR:1790614564462 2026-09-28T16:56:04.462Z daily 0.9 https://cdn.brandfetch.io/BUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Burford Capital shares are trading higher after the company announced a $1.4 billion entitlement if the patent case Taction Technology v. Apple payment was paid as is. openbell Financial News https://www.openbell.ai/news/RVMD:1790614549607 2026-09-28T16:55:49.607Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brookline Capital Initiates Coverage On Revolution Medicines with Buy Rating, Announces Price Target of $318 Brookline Capital analyst Leah Rush has initiated coverage on Revolution Medicines (NASDAQ: RVMD) with a Buy rating. The firm has set a price target of $318 for the stock. https://www.openbell.ai/news/LLY:1790614473061 2026-09-28T16:54:33.061Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Balding-Man-Showing-His-Head-With-Thin-H.jpg?width=250&height=187 FDA Expands Approval Of Eli Lilly's Olumiant For Adolescents with Autoimmune Hair Loss The FDA has expanded the approval of Eli Lilly's Olumiant (baricitinib) for adolescents aged 12 and older with severe alopecia areata, based on data from the BRAVE-AA-PEDS Phase 3 study. The study showed that 42% of patients receiving a 4 mg daily dose achieved 80% or greater scalp hair coverage at 36 weeks. Eli Lilly's shares rose 0.72% to $1192.03 following the announcement. Olumiant is already approved for adults with severe alopecia areata and rheumatoid arthritis. https://www.openbell.ai/news/MIRM:1790614416782 2026-09-28T16:53:36.782Z daily 0.9 https://cdn.brandfetch.io/MIRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $195 HC Wainwright & Co. analyst Swayampakula Ramakanth has reaffirmed a Buy rating on Mirum Pharmaceuticals (NASDAQ: MIRM) and increased the price target from $140 to $195. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/SPCX:1790614268101 2026-09-28T16:51:08.101Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deutsche Bank Reiterates Buy on SpaceX, Maintains $235 Price Target Deutsche Bank analyst Edison Yu has reiterated a Buy rating on SpaceX (NASDAQ: SPCX) while maintaining a price target of $235 for the stock. This affirmation reflects the bank's confidence in SpaceX's future performance. https://www.openbell.ai/news/FFAI:1790614155398 2026-09-28T16:49:15.398Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Faraday-Future.jpg?width=250&height=187 Faraday Future Stock Drops as Friday’s Rally Unwinds and Robotics Risks Resurface Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) shares fell by 11.02% to $1.43 on Monday, following a 22.9% rally on Friday. The decline is attributed to weakened market sentiment and concerns regarding the company's reliance on a China-linked robotics supply chain, with only 40% of necessary components sourced domestically. Faraday aims to establish a U.S. robot factory by year-end and has delivered over 500 robots this year, but execution risks remain as they push for localization. https://www.openbell.ai/news/CTVA:1790614037692 2026-09-28T16:47:17.692Z daily 0.9 https://cdn.brandfetch.io/CTVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Corteva Announces Seed Patent Suit Settlement With Inari, Which Will Destroy Corteva Material And Assign Related IP; Other Terms Confidential openbell Financial News https://www.openbell.ai/news/AGEN:1790614000697 2026-09-28T16:46:40.697Z daily 0.9 https://cdn.brandfetch.io/AGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Agenus shares are trading higher after Rodman & Renshaw initiated coverage on the stock with a Buy rating and announced a $19 price target. openbell Financial News https://www.openbell.ai/news/NAMI:1790613880536 2026-09-28T16:44:40.536Z daily 0.9 https://cdn.brandfetch.io/NAMI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Namibox shares are trading higher after the company signed a strategic cooperation memorandum with Pearson to jointly develop AI-driven learning solutions. openbell Financial News https://www.openbell.ai/news/MRK:1790613866917 2026-09-28T16:44:26.917Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/South-San-Francisco--Ca--Usa---May-1--20.jpg?width=250&height=187 Merck, Daiichi Sankyo Scrap FDA Application for Lung Cancer Drug Merck & Co. and Daiichi Sankyo have voluntarily withdrawn their U.S. Biologics License Application for the lung cancer drug ifinatamab deruxtecan (I-DXd) after discussions with the FDA revealed that the application data did not meet the requirements for accelerated approval. Despite this setback, the companies continue to enroll patients in the phase 3 IDeate-Lung02 trial and are evaluating the drug in additional studies for other cancers. Additionally, Merck announced a global license agreement with SciBrunch Therapeutics for an investigational oral KRAS G12D inhibitor, involving an upfront payment of $400 million and a total potential value of $2.13 billion.